Clinical decision support startup Aidoc has become a major player in healthcare AI thanks to its focus on acute, life-or-death cases and its R&D-first approach. As Aidoc continues to innovate, Chief Business Officer Tom Valent thinks its commitment to patient safety and transparency will be key contributors to future success.
Nvidia has quietly become one of the most influential players in healthcare technology by supplying the accelerated computing and AI infrastructure that powers everything from imaging to drug discovery. The company’s restraint — focusing on enabling the ecosystem rather than owning it — has helped cement its role as the indispensable backbone of the healthcare industry’s AI transformation.
CEO and neuroscientist Dr. Iftach Dolev on how the new device can bring a powerful tool to psychiatrists and neurologists alike.
The clinical decision support market is evolving quickly. With heavy investor backing and competing strategies around specialization, data depth and distribution, the coming years will determine which companies emerge as lasting leaders at the point of care.
Health tech companies made several major funding announcements in July. Here is a list of some of the biggest funding rounds.
Israeli clinical AI startup Aidoc raised $150 million in a funding round led by General Catalyst and Square Peg, with participation from four U.S. health systems. The company has more than 150 health system customers.
Here are nine notable announcements shared at the HLTH conference held this week in Las Vegas.
Alan Murray on improving access for medical transportation.
Aidoc, a Tel Aviv-based startup providing software to help radiologists triage scans, closed a $110 million funding round on Thursday. The company will use the money to expand its AI platform and develop care coordination tools for various specialties instead of focusing solely on radiology.
Aidoc, a Tel Aviv-based startup building a suite of decision support tools for radiologists, raised $66 million in funding. The company plans to use the funds to build out and market its suite of radiology solutions.
The regulatory clearance would allow AIdoc’s system to be used to detect incidental pulmonary embolism, meaning that it could flag unsuspected findings in CT scans.
Aidoc received authorization from the Food and Drug Administration to use its algorithms to detect likely Covid-19 cases in CT scans. The FDA issued guidelines allowing vendors with cleared triage solutions to expand their coverage to Covid-19.
Greenway Health blends smart technology with human expertise to elevate revenue cycle.
Most AI-powered startups in radiology tackle an image problem, but Rad AI have been focused on a workflow problem by automatically generating the impressions section of a radiologist’s report, which is a summary of the report’s other sections.
The regulatory decision comes just a few weeks after the FDA cleared the company's pulmonary embolism product.
The FDA decision, which builds on a prior approval of the company's algorithm for the detection of intracranial hemorrhages through CT scans, is part of a larger vision sketched out by CEO Elad Walach of plugging new algorithms into the Aidoc system to create a new standard of care in radiology.
Aidoc pitches its product as a way to more quickly scan and detect potential issues in medical images.
The Tel Aviv, Israel-based startup is leveraging artificial intelligence and deep learning to improve the radiology workflow. Its technology pinpoints abnormalities in a medical image.